• About
  • Contact
Saturday, January 16, 2021
No Result
View All Result
Londoner News
  • Home
  • London
  • Britain
  • Europe
  • America
  • International
  • Submit Article
  • Other
    • Health
    • Tech
    • Travel
    • Science
  • Home
  • London
  • Britain
  • Europe
  • America
  • International
  • Submit Article
  • Other
    • Health
    • Tech
    • Travel
    • Science
No Result
View All Result
Londoner News
No Result
View All Result
Home Markets

Biocon posts marginal 2 per cent growth in net profit for Q4FY18

by The Editor
April 26, 2018
in Markets
0
Biocon posts marginal 2 per cent growth in net profit for Q4FY18
0
SHARES
0
VIEWS
Share on FacebookShare on Twitter

NEW DELHI: Indian biotechnology major Biocon on Thursday posted around 2% increase in its net profit for the fourth quarter of the 2017-18 financial year.

Biocon posted a net profit of Rs 130 crore for the quarter ended March 31, 2018. The company had recorded a net profit of Rs 127 crore for the same quarter in the last fiscal year.

Its total revenue for this quarter grew 27% to 1,237 crore as compared to Rs 974 crore for the same quarter in the 2016-2017 financial year.

At the same time, the companys net profit for the entire financial year dropped 39% to Rs 372 crore for FY18 compared to Rs 612 crore in FY17.

Its total revenue for the 2017-18 financial year grew 6% to Rs 4,336 crore compared to Rs 4,079 crore during the previous financial year.

“The muted FY18 performance was on account of continued pricing challenges in the generics business coupled with a planned plant shut down for requalification and lower licencing income in the biologics business,” stated Kiran Mazumdar-Shaw, Biocons managing director. “In addition, operational expenses related to our Malaysia facility impacted the bottom line,” she said.

“However, a positive Q4 is indicative of a normalized business trend. Recent approvals of our biosimilars along with the strong performance of Syngene are expected to positively impact overall performance in FY19,” she added.

Biocons board also recommended a final dividend of Rs 1 per equity share, according to its filing to the Bombay Stock Exchange.

Share prices of Biocon on Thursday closed at Rs 663.25 apiece, up 1.45% from the previous close on the Bombay Stock Exchange, where the benchmark Sensex ended 0.62% higher.

Original Article

[contf] [contfnew]

ET Markets

[contfnewc] [contfnewc]

The Editor

The Editor

Next Post
Technology sector is now central to stock market performance

Technology sector is now central to stock market performance

Leave a Reply Cancel reply

Your email address will not be published. Required fields are marked *

Recommended

20 cats missing after ‘out of control’ hounds tear through animal sanctuary (VIDEO)

20 cats missing after ‘out of control’ hounds tear through animal sanctuary (VIDEO)

3 years ago
Australian shares rise on banks and materials; New Zealand jumps

Australian shares rise on banks and materials; New Zealand jumps

3 years ago

Popular News

    Connect with us

    About Us

    We bring you the best Premium WordPress Themes that perfect for news, magazine, personal blog, etc. Check our landing page for details.

    Category

    • America
    • Britain
    • Europe
    • Health
    • International
    • latest news
    • London
    • Markets
    • Science
    • Tech
    • Travel
    • Women

    Site Links

    • Log in
    • Entries feed
    • Comments feed
    • WordPress.org
    • About
    • Contact

    © 2020 londonernews

    No Result
    View All Result
    • Home
    • Science
    • Travel
    • Tech
    • Health

    © 2020 londonernews